These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 15182581)
1. [Study of the effect of TF/FVIIa complex on the expression of u-PAR mRNA in human ovarian cancer]. Fang J; Wei WN; Xia LH; Song SJ Zhonghua Xue Ye Xue Za Zhi; 2004 Mar; 25(3):143-6. PubMed ID: 15182581 [TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer. Taniguchi T; Kakkar AK; Tuddenham EG; Williamson RC; Lemoine NR Cancer Res; 1998 Oct; 58(19):4461-7. PubMed ID: 9766679 [TBL] [Abstract][Full Text] [Related]
3. [The effects of tissue factor/activated factor VII complex on the invasion and metastasis of human ovarian cancer]. Fang J; Wei WN; Xia LH; Song SJ Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):523-7. PubMed ID: 15569528 [TBL] [Abstract][Full Text] [Related]
4. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells. Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828 [TBL] [Abstract][Full Text] [Related]
5. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma. De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771 [TBL] [Abstract][Full Text] [Related]
6. Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells. Tavian D; Salvi A; De Petro G; Barlati S Cancer Gene Ther; 2003 Feb; 10(2):112-20. PubMed ID: 12536199 [TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of urokinase-type plasminogen activator, its receptor, and type 2 inhibitor in giant cell tumor of bone]. Li H; Dong S; Zeng Y Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):386-8. PubMed ID: 11810768 [TBL] [Abstract][Full Text] [Related]
8. [Cloning of expression vector of human tissue factor gene and its expression in human ovarian cancer cell line]. Fang J; Wei WN; Liu ZP; Song SJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):579-82. PubMed ID: 14706138 [TBL] [Abstract][Full Text] [Related]
9. Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa. Aberg M; Wickström M; Siegbahn A Thromb Res; 2008; 122(2):191-202. PubMed ID: 18031796 [TBL] [Abstract][Full Text] [Related]
10. [Clinical study of hemostatic molecular markers expression in patients with cancer]. Wu F; Qu B; Wang XF; Yang CM; Wang HL Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):837-40. PubMed ID: 15634544 [TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients]. Zhou Q; Liang LJ; Peng BG; Zhen YY Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of plasma tissue factor pathway and urokinase-type plasminogen activator system in cancer patients. Zhao W; Wang X; Qu B; Huang X; Wang H Chin Med J (Engl); 2002 May; 115(5):702-4. PubMed ID: 12133538 [TBL] [Abstract][Full Text] [Related]
13. Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer. Chanakira A; Westmark PR; Ong IM; Sheehan JP Gynecol Oncol; 2017 Apr; 145(1):167-175. PubMed ID: 28148395 [TBL] [Abstract][Full Text] [Related]
14. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600 [TBL] [Abstract][Full Text] [Related]
15. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma. Ma JJ; Chen BL; Xin XY Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744 [TBL] [Abstract][Full Text] [Related]
16. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637 [TBL] [Abstract][Full Text] [Related]
17. Native atherosclerosis and vein graft arterialization: association with increased urokinase receptor expression in vitro and in vivo. Okada SS; Golden MA; Raghunath PN; Tomaszewski JE; David ML; Kuo A; Kariko K; Barnathan ES Thromb Haemost; 1998 Jul; 80(1):140-7. PubMed ID: 9684800 [TBL] [Abstract][Full Text] [Related]
18. The ovine urokinase plasminogen activator and its receptor cDNAs: molecular cloning, characterization and expression in various tissues. Theodorou G; Bizelis I; Rogdakis E; Politis I Gene; 2009 Aug; 443(1-2):158-69. PubMed ID: 19389465 [TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Leupold JH; Yang HS; Colburn NH; Asangani I; Post S; Allgayer H Oncogene; 2007 Jul; 26(31):4550-62. PubMed ID: 17297470 [TBL] [Abstract][Full Text] [Related]
20. [Effect of down regulation of laminin receptor on urokinase-type plasminogen activator expression in human bile duct carcinoma cells]. Wang SG; Chen CH; Li DJ; Li K Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1642-4. PubMed ID: 15569461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]